Chief Supervisor

Dr DO Chi-wai

Project Title

Bionic Nano platform for the delivery of anti-glaucoma agents

Synopsis

Glaucoma is a leading cause of visual impairment and blindness worldwide. It is a neurodegenerative disease with elevated intraocular pressure (IOP) as an important risk factor. Currently, there is no cure for glaucoma. Lowering IOP is the only clinical intervention proven to be effective in slowing the progression of glaucomatous blindness. There is a huge need for developing more efficacious treatments to halt or even reverse glaucoma progression. Natural flavonoids have been shown to be the potential anti-glaucoma agents. The aim of the project is to develop novel nanotechnology-based strategies to improve the stability and bioavailability of potential anti-glaucoma drugs.